… Overview of studies on NfL in multiple sclerosis (MS) or … clinically definite multiple sclerosis
… correlation of serum NfL with acute and long-term clinical outcome in these patients. …

… CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis. J …
Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients. …

… no demonstrated biomarkers to predict the response to daclizumab or any adverse effects. …
for large consortia to carry them out, the long-term benefits are clear. PM is probably more …

… Multiple sclerosis (MS) is the most common demyelinating disease and characterized by
immunological changes. Oligoclonal bands of IgG in CSF not … progression in the long term. If we …

… Here, oligoclonal immunoglobulin M (… multiple sclerosis severity score (MSSS), a clinical
measure of disease severity. All these studies provide proof for the involvement of lipid-specific …

… -Rial, J., Hedstrom, AK, Hillert, J., Alvarez-Cermeno, JC, Masterman, T., Villar, LM Lipid-specific
immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis. Mult …

… outcome measures that incorporate clinical and MRI data are best for predicting long-term …
Some evidence suggests that immunoglobulin M (IgM) OCBs could also be prognostic …

… Lipid-specific IgM oligoclonal bands (LS-OCMBs) predict an … LS-OCMBs also predict an
earlier clinical conversion to MS … All long-term trials of RRMS show evidence of a negative …

… in the mid and long-term follow-up 3,5,7,8 . … that we did not measure lipid-specific IgM-OB
in the CSF, though this is … high proportion of IgG-OB false-negatives in predicting the course of …

… Moreover, the presence of lipid-specific OCMB was associated with a poorer response to
IFNβ … Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of …